Stanley N. Caroff, MD

  • 12Articles
  • 67KReads
  • 2001–2024Active
  • 77Collaborators
  • 759Citations

About

Stanley N. Caroff, MD, is affiliated with the University of Pennsylvania Perelman School of Medicine in Philadelphia. His publications from 2001 to 2024 focus on neurological and psychiatric conditions, including schizophrenia, schizoaffective disorders, depression, and movement disorders such as tardive dyskinesia and neuroleptic malignant syndrome. His work includes the development and evaluation of clinical tools for assessing tardive dyskinesia, consensus studies on diagnosis and treatment criteria, and investigations into treatment outcomes and risks associated with antipsychotic medications. He has frequently collaborated with co-authors such as E. Cabrina Campbell and Stephan C. Mann.

Publications

JCP
The Clinician’s Tardive Inventory
Original Research

The Clinician’s Tardive Inventory

January 24, 2024

Accurately identifying the severity and functional impact of tardive dyskinesia is essential. This report describes a new instrument, the Clinician’s Tardive Inventory, which aims to address shortcomings of existing...
, , , et al
JCP
Consensus Statement

Screening, Diagnosis, and Treatment of Tardive Dyskinesia

January 28, 2020

Tardive dyskinesia remains a serious complication associated with dopamine receptor blocking agents. In this article, read guidance from experts on best practices for tardive dyskinesia screening, diagnosis, and treatment.
, , , et al
JCP
Consensus Statement

Revisiting the Use of the AIMS in Tardive Dyskinesia Trials

May 8, 2018

The authors of this consensus statement look at the history of the use of the Abnormal Involuntary Movement Scale in tardive dyskinesia studies and outline the challenges of using...
, , , et al
JCP
Original Research

Feasibility and Pilot Efficacy Results From the Multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) Randomized Controlled Trial

May 15, 2012

, , , et al
JCP
Original Research

An International Consensus Study of Neuroleptic Malignant Syndrome Diagnostic Criteria Using the Delphi Method

June 28, 2011

, , , et al
JCP
Original Research

Treatment Outcomes of Patients With Tardive Dyskinesia and Chronic Schizophrenia

August 10, 2010

, , , et al
JCP
Original Research

A Meta-Analysis of the Risk of Acute Extrapyramidal Symptoms With Intramuscular Antipsychotics for the Treatment of Agitation

December 31, 2008

, , , et al
JCP
Original Research

Treatment of Tardive Dyskinesia With Galantamine: A Randomized Controlled Crossover Trial

March 15, 2007

, , , et al
PCC
Article

Movement Disorders Associated With Atypical Antipsychotic Drugs

April 1, 2002

, , , et al
JCP
Article

Movement Disorders Associated With Atypical Antipsychotic Drugs

April 1, 2002

, , , et al
JCP
Original Research

Treatment of Tardive Dyskinesia With Donepezil: A Pilot Study

October 1, 2001

, , , et al
JCP
Letter to the Editor

Treatment of Tardive Dyskinesia With Donepezil

February 2, 2001

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe